文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性广泛性疼痛在普通人群中的流行率:一项系统综述。

Chronic widespread pain prevalence in the general population: A systematic review.

机构信息

Institute for Allied Health Research, Glasgow Caledonian University, UK.

出版信息

Eur J Pain. 2018 Jan;22(1):5-18. doi: 10.1002/ejp.1090. Epub 2017 Aug 17.


DOI:10.1002/ejp.1090
PMID:28815801
Abstract

UNLABELLED: Chronic widespread pain (CWP) is a significant burden in communities. Understanding the impact of population-dependent (e.g., age, gender) and contextual-dependent (e.g. survey method, region, inequality level) factors have on CWP prevalence may provide a foundation for population-based strategies to address CWP. Therefore, the purpose of this study was to estimate the global prevalence of CWP and evaluate the population and contextual factors associated with CWP. A systematic review of CWP prevalence studies (1990-2017) in the general population was undertaken. Meta-analyses were conducted to determine CWP prevalence, and study population data and contextual factors were evaluated using a meta-regression. Thirty-nine manuscripts met the inclusion criteria. Study CWP prevalence ranged from 1.4% to 24.0%, with CWP prevalence in men ranging from 0.8% to 15.3% and 1.7% to 22.1% in women. Estimated overall CWP prevalence was 9.6% (8.0-11.2%). Meta-regression analyses showed gender, United Nations country development status, and human development index (HDI) influenced CWP prevalence, while survey method, region, methodological and reporting quality, and inequality showed no significant effect on the CWP estimate. Globally CWP affects one in ten individuals within the general population, with women more likely to experience CWP than men. HDI was noted to be the socioeconomic factor related to CWP prevalence, with those in more developed countries having a lower CWP prevalence than those in less developed countries. Most CWP estimates were from developed countries, and CWP estimates from countries with a lower socioeconomic position is needed to further refine the global estimate of CWP. SIGNIFICANCE: This systematic review and meta-analysis updates the current global CWP prevalence by examining the population-level (e.g. age, gender) and contextual (e.g. country development status; survey style; reporting and methodologic quality) factors associated with CWP prevalence. This analyses provides evidence to support higher levels of CWP in countries with a lower socioeconomic position relative to countries with a higher socioeconomic position.

摘要

背景:慢性广泛性疼痛(CWP)是社区中一个重大的负担。了解人口相关因素(如年龄、性别)和情境相关因素(如调查方法、地区、不平等程度)对 CWP 患病率的影响,可能为基于人群的策略提供基础,以解决 CWP 问题。因此,本研究的目的是估计全球 CWP 的患病率,并评估与 CWP 相关的人口和情境因素。对 1990 年至 2017 年期间一般人群中 CWP 患病率的研究进行了系统回顾。进行荟萃分析以确定 CWP 的患病率,并使用荟萃回归评估研究人群数据和情境因素。符合纳入标准的有 39 篇文献。研究 CWP 的患病率范围为 1.4%至 24.0%,男性的 CWP 患病率为 0.8%至 15.3%,女性的 CWP 患病率为 1.7%至 22.1%。估计的总体 CWP 患病率为 9.6%(8.0-11.2%)。荟萃回归分析表明,性别、联合国国家发展状况和人类发展指数(HDI)影响 CWP 的患病率,而调查方法、地区、方法学和报告质量以及不平等对 CWP 估计没有显著影响。全球范围内,每 10 个人中就有 1 个人患有 CWP,女性比男性更容易患有 CWP。注意到 HDI 是与 CWP 患病率相关的社会经济因素,较发达国家的 CWP 患病率低于欠发达国家。大多数 CWP 估计来自发达国家,需要来自社会经济地位较低的国家的 CWP 估计来进一步完善全球 CWP 估计。 意义:本系统回顾和荟萃分析通过检查与 CWP 患病率相关的人口水平(如年龄、性别)和情境(如国家发展状况;调查方式;报告和方法学质量)因素,更新了当前全球 CWP 的患病率。该分析为社会经济地位较低的国家的 CWP 水平相对较高提供了证据。

相似文献

[1]
Chronic widespread pain prevalence in the general population: A systematic review.

Eur J Pain. 2017-8-17

[2]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[3]
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Health Technol Assess. 2006-8

[4]
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Health Technol Assess. 2006-7

[5]
Interventions targeted at women to encourage the uptake of cervical screening.

Cochrane Database Syst Rev. 2021-9-6

[6]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2022-5-23

[7]
Prophylactic mastectomy for the prevention of breast cancer.

Cochrane Database Syst Rev. 2004-10-18

[8]
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Health Technol Assess. 2007-4

[9]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[10]
Psychological and/or educational interventions for the prevention of depression in children and adolescents.

Cochrane Database Syst Rev. 2004

引用本文的文献

[1]
Pain in the body, harm to the heart: advances in research on the impact of chronic pain on cardiovascular diseases.

Front Cardiovasc Med. 2025-8-6

[2]
Sex-Related Differences in Chronic Pain: A Narrative Review by a Multidisciplinary Task Force.

Medicina (Kaunas). 2025-6-28

[3]
Predicting chronic pain using wearable devices: a scoping review of sensor capabilities, data security, and standards compliance.

Front Digit Health. 2025-5-22

[4]
Indolepropionic Acid Attenuates CFA-Induced Inflammatory Pain in Mice.

J Pain Res. 2025-5-23

[5]
Quality of Life in European Adults and Older with All-Over Pain: Relationship with Frequency of Moderate and Vigorous Physical Activity and Decision Prediction Models with Cross-Sectional Data.

Healthcare (Basel). 2025-5-17

[6]
Navigating Pregnancy Testing in Chronic Pain Management for Women of Reproductive Age.

J Pain Res. 2025-5-21

[7]
Opioid Therapy in Chronic Pain: Assessment of Clinical Outcomes and Relationships With Endocrine Biomarkers.

Eur J Pain. 2025-7

[8]
Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol.

PLoS One. 2025-4-16

[9]
Pain Self-Management Behaviors in Breast Cancer Survivors Six Months Post-Primary Treatment: A Mixed-Methods, Descriptive Study.

Cancers (Basel). 2025-3-24

[10]
Subcutaneous Lidocaine Infusion for Chronic Widespread Pain: A Chart Review and Survey Examining the Safety and Tolerability of Treatment.

J Clin Med. 2025-4-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索